Phio Pharmaceuticals logo
Phio Pharmaceuticals
PHIO | NASDAQ
Chart Builder DCF Calculator
$0.75
-$0.02 (-2.72%)
At close: Nov 16, 2026, 4:00 PM ET
$0.77
+$0.02 (+2.80%)
After-hours: Nov 16, 2026, 7:30 PM ET

Phio Pharmaceuticals Company Profile

Company profile explained

Company Profile

Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.

Key Executives

Name Position
Robert J. Bitterman President, Chief Executive Officer & Chairman
Jennifer Phillips Senior Vice President of Regulatory & Corporate Affairs
Linda Mahoney Senior Vice President of Development
Lisa Carson CFO, Principal Accounting Officer and VP of Finance & Administration

Latest SEC Filings

Date Type Title
Oct 13, 2026 8-K Current Report
Sep 30, 2026 4 Filing
Sep 29, 2026 4 Filing
Sep 29, 2026 4 Filing
Sep 29, 2026 4 Filing
Sep 28, 2026 S-8 Filing
Sep 28, 2026 8-K Current Report
Sep 25, 2026 4 Filing
Sep 23, 2026 4 Filing
Sep 16, 2026 4 Filing
View All SEC Filings ➞
Phio Pharmaceuticals
Phio Pharmaceuticals logo
Country United States
IPO Date May 10, 2012
Industry Biotechnology
Sector Healthcare
Employees 6
CEO Robert L. Bitterman

Contact Details

411 Swedeland Road King of Prussia, Pennsylvania 19406 United States

Stock Details

Ticker Symbol PHIO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001533040
CUSIP Number 71880W501
ISIN Number US71880W5013
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.